AbbVie

AbbVie Inc. is an American biopharmaceutical company based in the United States. It was formed in 2013 as a spin-off from Abbott Laboratories. AbbVie focuses on research and development of advanced therapies in immunology, oncology, neuroscience, eye care, and virology. Its best-known product is Humira, one of the world's top-selling drugs, along with newer therapies like Rinvoq and Skyrizi. The company employs about 50,000 people and operates in over 75 countries. AbbVie continues to grow through acquisitions, including its 2020 purchase of Allergan. It is publicly traded on the New York Stock Exchange (NYSE: ABBV). AbbVie delivers services and products across multiple industries, with a focus on innovation, customer needs, and regulatory compliance. The company engages in strategy development, technological advancement, and partnerships with a wide client base. Through investments in research, infrastructure, and employee development, AbbVie supports long-term growth. The company's portfolio spans solutions that address complex demands in an evolving global landscape. As part of its mission, AbbVie emphasizes sustainable practices, ethical governance, and resilience. In addition, AbbVie has implemented systems to manage risk, security, and operational efficiency.